On Friday, Starwood shareholders will vote on whether to approve the deal, with the board of directors supporting the deal. Normally these types of events aren't very noteworthy.
But Cramer, the co-manager of the Action Alerts PLUS portfolio, is watching for other implications as well: The government. He's wondering if regulators will start analyzing the Chinese for wanting to buy U.S. stocks and companies.
Maybe that wouldn't be a concern, if the government hadn't blocked the mega-merger between Allergan (AGN - Get Report) and Pfizer (PFE - Get Report) , and the tie-up between Baker Hughes (BHI) and Halliburton (HAL - Get Report) within a few days of each other.
The government is everywhere, Cramer said, adding that there may be chatter from investors surrounding the Starwood-Marriott deal about whether regulators will start to play an even larger role in M&A going forward.